Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15010 total
Cincinnati Financial has pulled back since its Q2 report, and the Street's reaction tells a cleaner story than the result itself did. The stock closed at $179.42, down roughly 7% from the $184.23 level it carried into…
Charles River Laboratories reported Q2 earnings on August 5, and the week's most telling shift is not in the short book — which stayed quiet — but in the options market, where put demand has jumped to its most elevated…
Lumen Technologies reported Q2 results on August 4 and rose 4% on the day — but the Street's immediate response was to cut targets, not raise them, leaving the stock trading nearly 20% below the consensus mean and…
Caterpillar has done the hard work in 48 hours — the Q2 print delivered a 7.5% gap-up and the stock closed Tuesday at $876.54, clawing back roughly a third of July's brutal losses — and now the question the Street must…
Capital Southwest Corporation posted a 3.3% gain on Tuesday after reporting earnings, and the week's most interesting tension is no longer whether the print would resolve the long-vs-short standoff — it did, decisively…
CALY reported results on August 6 with the stock already up 7% on the week — leaving the short buildup that accumulated through July facing an uncomfortable tape. The positioning story heading into the print was one of…
CVS Health reported its Q2 results on August 5 and the immediate verdict from the market is a 4.5% weekly loss, even as the analyst community keeps its targets well above where the stock now trades. The price action…
CECO Environmental heads into its August 10 earnings report with short sellers rebuilding aggressively and the stock sitting 14% below its June peak — the tension between a bullish analyst consensus and a surge in…
Materion Corporation is coming off its best week in months, rallying 8.3% to $227.10, even as it remains down more than 14% over the prior month — a rebound that is arriving just as short sellers have been steadily…
Azenta has just delivered its fiscal Q3 earnings — the setup heading into the print was as charged as any in the life sciences tools space this week, and the reaction over the next session will determine whether the…
Bristol-Myers Squibb has cleared Q2 and the setup has flipped — the shorts that were rebuilding ahead of the July 30 print are now unwinding, while a wave of analyst upgrades and target hikes is pushing the stock to…
BXP enters the first week of August with short sellers rebuilding positions after the stock's post-earnings jump, even as the borrow market and analyst community signal the bears face little structural tailwind. The…
BA has extended its post-earnings momentum into a second week, closing at $237.16 — up 7% on the week and now sitting 15.6% above where it was trading just three weeks ago — with a dramatic analyst upgrade arriving to…
Bio-Rad Laboratories heads into the post-earnings stretch with a sharp divergence between what options markets are saying and what short sellers are actually doing. The clearest signal this week is in options. Demand…
BancFirst Corporation heads into early August with its own chairman liquidating tens of millions in stock — even as peers across the regional banking space post stronger weekly gains. The dominant story this week is…
Ball Corporation arrives at its August 6 earnings release with analyst opinion freshly split, a stock down 4.7% on the week, and options traders less bearish than the price action alone would suggest. The most…
ADP has extended its post-earnings rally into the new week, with the stock climbing another 2.4% to $270.62 — and the analyst community scrambling to lift targets that still lag the price. The most striking development…
Archer-Daniels-Midland bounced 2.3% on Tuesday to close at $79.87, but the recovery lands in an analytically awkward spot — the stock is now trading just above the Morgan Stanley bear camp's freshly raised target, and…
AAPL has spent the first days of August trying to find a floor after July's earnings-driven collapse, trading at $309.38 — still well below the Street's mean target of $320.89 and with analysts openly divided on…
AMGN exits its August 4 earnings print into a wave of upward analyst revisions, with the stock up nearly 3% on the day and a consensus that — for the first time in weeks — has started to catch up to where the shares…
